Categories: Healthcare

Novo Nordisk to buy Prothena’s heart drug in deal worth up to $1.2 bln

July 12 (Reuters) – Danish drugmaker Novo Nordisk (NOVOb.CO) will acquire U.S. drug developer Prothena Corp’s (PRTA.O) experimental heart therapy, PRX004, in a deal that could be worth up to $1.23 billion, the companies said on Monday.

The acquisition is in line with Novo’s strategy to diversify its core insulin portfolio that has been facing tough competition, prompting it to turn toward newer diabetes and obesity drugs to revive growth.

Under the agreement, Prothena will receive $100 million in upfront and near-term clinical milestone payments for PRX004, currently in a mid-stage trial.

Prothena in December had reported positive data from an early-stage trial of PRX004 to treat hereditary ATTR amyloidosis, a life-threatening genetic disease that affects the heart, nerves and other organs.

Novo Nordisk said it would focus on developing PRX004 for ATTR cardiomyopathy, a potentially fatal form of the disease characterized by a build-up of amyloid deposits in cardiac tissue.

The Danish firm in June last year had agreed to buy AstraZeneca (AZN.L) spin-off Corvidia Therapeutics for an initial $725 million to expand into cardiovascular disease treatments.

Prothena’s pipeline includes drugs being developed to treat several neurodegenerative diseases including Alzheimer’s disease and Parkinson’s as well as disorders like AL amyloidosis.Reporting by Dania Nadeem in Bengaluru; Editing by Ramakrishnan M.

Our Standards: The Thomson Reuters Trust Principles.

Source: https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-buy-prothenas-heart-drug-deal-worth-up-12-bln-2021-07-12/

World Economic Magazine

Recent Posts

Morgan Stanley Agrees to Buy Vinyl Equity for Shareholder Services

The pending acquisition would add transfer-agent and ownership-record capabilities to Morgan Stanley at Work; the…

13 hours ago

Goodyear Installs Roger Wood as Interim CEO During Strategic Review

Mark Stewart exits immediately as the board continues examining the company’s business mix, footprint and…

2 days ago

Securitize Seeks a Lending Foothold With River One Acquisition

The pending deal would connect asset-backed financing with its tokenization business, but market-size figures do…

3 days ago

LKQ Accelerates Sal Abbate’s Arrival as Chief Executive

The automotive-parts supplier ends its interim leadership arrangement more than a month ahead of the…

3 days ago

U.S. and 14 Partners Set Agenda on Manufacturing Excess Capacity

A joint ministerial statement calls for sectoral discussions and an end to market-distorting policies, without…

4 days ago

Aruba Signs Battery Deal to Coordinate Its Power System

Wärtsilä’s 35-megawatt storage project pairs batteries with energy management and maintenance, with takeover expected in…

5 days ago